Positionnement dans le cursus
Semestre 5
Intersemestre
Semestre 6
 
 
 
Semestre 7
 
Intersemestre
Semestre 9
 
 
Intersemestre

Course unit

Therapeutics and health risks

Last updated: 22/02/2024

Edit

Course Director(s):

POURCHEZ Jérémie

General Description:

Students will follow an introduction to the emerging and inter-disciplinary discipline of nanomedicine. They will in addition be made aware of health risks at work.

Key words:

Nanomedicine Nanotoxicity Health risks

Number of teaching hours

40

Fields of study

Biological engineering, Medical engineering Materials Science

Teaching language

French English

Intended learning outcomes

On completion of the unit, the student will be capable of: Classification level Priority
Acquiring the basic concepts of the emerging and inter-disciplinary disciplines of nanomedicine and nanotoxicology 2. Understand null
Raising awareness of health risks in a company environment and in particular oncogenic risks (prevention methods, risk management…) 4. Analyse
Acquiring knowledge in the physico-chemistry of solids in order to understand the impact of these parameters on vectorisation (notion of bio-distribution) or the biological activity (toxicity) of nanoparticles 5. Summarise

Learning assessment methods

Percentage ratio of individual assessment Percentage ratio of group assessment
Written exam: 100 % Project submission: %
Individual oral exam: % Group presentation: %
Individual presentation: % Group practical exercise: %
Individual practical exercise: % Group report: %
Individual report: %
Other(s): %

Programme and content

Type of teaching activity Content, sequencing and organisation
Course

As a form of introduction students will study the definitions and framework of nanomedicine. They will also see the nanomaterials used in nanomedicine (the different types, properties, applications). They will refer to physico-chemical aspects (nanomaterial synthetics) and biological aspects (what becomes of nanoparticles in the organism). Finally they will study application examples (nanovectorisation, drug delivery).

Course

Students will be made aware of health risks in a company environment. In particular the prevention approach to oncogenic risks will be presented by describing chemical, biological and physical risks.

There will be a focus on the potential toxicity of nanomaterials (description of the biological mechanisms involved, origins, pathology, experimental approaches).